Cue Biopharma (CUE) has disclosed a new risk, in the Share Price & Shareholder Rights category. Cue Biopharma faces a significant risk ...

Nvidia's results cap a mixed third-quarter earnings season for U.S. companies. S&P 500 earnings are on pace to have risen 8.8 ...

Cantor Fitzgerald’s “Tracker Quants” laid out its forecasted changes for the upcoming Nasdaq 100 Index review. Nasdaq will ...

Shares in Palantir Technologies Inc were up more than 6% on Friday, hitting a record high, after it announced late on ...

Palantir (PLTR) will transfer its stock listing from NYSE to Nasdaq on Nov. 26. This move could potentially lead to inclusion ...

Palantir Technologies shares jumped Friday after the analytics software provider said it is shifting its listing to the ...

The change positions Palantir for entry into the Nasdaq 100 index, after it joined the S&P 500 several months back.

Data source: Finviz and YCharts on 11/13/2024. Table by author. Nvidia and Arm Holdings benefit from the ongoing frenzy for ...

QQQX offers monthly income through covered calls, ideal for income-focused investors, but may lead to capital erosion in ...

Announced Exclusive Licensing Agreement with Viatris for Sotagliflozin in all Markets Outside of the U.S. and EuropeCompleted ZYNQUISTA™ FDA ...